Healthetech, Inc. SMART Study

计划入组 56 人 · 首次发布于 2005 年 9 月 19 日

Opinions of Company Representatives About Neuromodulation

计划入组 39 人 · 首次发布于 2021 年 8 月 19 日

EyeKon Medical Inc. Capsular Tension Ring Study

计划入组 125 人 · 首次发布于 2015 年 1 月 6 日

Orphanin antagonists (The GI company)

UC1MT (Biohaven Pharmaceutical Holding Company/University of Connecticut)

APP targeted antibody(Genome & Company)

Pascal Company, Inc.

United States

Lannett Company Inc.

United States

Vaccine Company, Inc.

United States

Hoth Therapeutics' HT-KIT Shows Promising Preclinical Results in KIT-Driven Cancers

Metsera's MET-097i Shows Promise in Phase I/II Obesity Trial, Advancing to Phase II

Biofrontera Inc. Negotiates Strategic Partnership Changes with German Parent Company